Indovax Private Limited, headquartered in Gurugram, India, is a leading manufacturer of high-quality poultry vaccines, serving domestic and international markets with a comprehensive portfolio of live and inactivated vaccines. Established in 1989, Indovax has played a pivotal role in the Indian poultry industry's growth by delivering scientifically validated and affordable disease prevention solutions.
With its state-of-the-art production and R&D facilities, Indovax is committed to safeguarding poultry health and enhancing biosecurity across poultry value chains. The company operates under the technical guidance of international vaccine experts and follows globally recognized production standards to meet the needs of commercial poultry operations and integrated producers worldwide.
Core Business
Indovax specializes in the development, production, and marketing of poultry vaccines, targeting both viral and bacterial diseases that significantly impact flock productivity. The company focuses on:
- Live attenuated vaccines for broilers, layers, and breeders
- Inactivated vaccines for booster and layer protection
- Custom vaccines and autogenous solutions tailored to regional disease profiles
Indovax’s vaccines are widely used across hatcheries, farms, integrators, and poultry health programs in India and overseas.
Product and Service Offerings
Live Vaccines
- F STRAIN – For Infectious Laryngotracheitis (ILT)
- LASOTA STRAIN – Newcastle Disease (ND)
- MUKTESHWAR STRAIN (R2B) – Newcastle Disease (ND), mesogenic strain
- GEORGIA STRAIN – Infectious Bronchitis
- BURSA B2K – Infectious Bursal Disease (IBD)
- MAREK'S DISEASE VACCINE (Cell Free and Cell Associated)
- BRONKICHICK, BRONKI-F, BRONKI-L – Infectious Bronchitis vaccines
- FOWL POX VACCINE
- ELEMBEE – Combination vaccine
- LASOTA ET CLONE – Improved ND strain for high immunogenicity
Inactivated Vaccines
- ENCIVAX, ENCIVAX-M – Inactivated ND vaccines
- BRONKIVAX – Inactivated Infectious Bronchitis vaccine
- FC VAX – Fowl Cholera
- HP VAX – Hydropericardium Syndrome vaccine
- CORYVAX – Coryza vaccine
- POLYVAX series (NB, NG, NBG) – Multivalent vaccines combining ND, IB, IBD
- VAXELLA-FT – Salmonella-based vaccine
Indovax vaccines are available in a wide range of vial and dose configurations, with product support and usage guidance offered through a nationwide technical network.
Specialisation and Core USP
Indovax’s unique strength lies in its exclusive focus on avian vaccines and its in-depth understanding of regional poultry disease dynamics. Key USPs include:
- In-house production of SPF (Specific Pathogen Free) eggs, ensuring high-purity vaccine seed stock
- Comprehensive multivalent vaccine formulations reducing the need for multiple injections
- Custom manufacturing capabilities to address local disease strains
- Research-driven antigen selection and adjuvant optimization
The company is also a preferred partner for integrators and poultry health programs due to its robust quality control and batch consistency.
Financials
While Indovax is privately held and does not disclose public financial data, key operational indicators include:
- Production capacity exceeding 1 billion doses annually
- Significant market share in India’s poultry vaccine segment
- Export activities across Asia, Middle East, and Africa
- Multiple supply contracts with government poultry health missions
- Continuous capital investments in GMP-compliant manufacturing and cold chain systems
The company’s strong supply chain and cost-efficient production model support sustainable growth and client retention.
Shipments and Usage Metrics
Trade and industry reports indicate:
- Presence in over 25 countries, including Bangladesh, Sri Lanka, Nepal, Kenya, UAE, and Egypt
- Annual domestic distribution to thousands of commercial poultry farms across India
- Major supplier in layer and broiler vaccination programs, especially in high-density poultry zones of South and West India
- Export volumes increasing steadily over the last five years due to recognition of Indovax’s reliable cold chain and product efficacy
Products like Marek's Disease Vaccine, Mukteshwar R2B, and POLYVAX-NBG are among the most widely adopted.
Target Market
Indovax serves a broad clientele in the poultry sector:
- Broiler and layer integrators
- Hatcheries and day-old chick suppliers
- Veterinary pharma distributors
- Government poultry health programs
- Animal husbandry departments
- Veterinary hospitals and diagnostic labs
Its technical support teams also work closely with veterinary consultants and academic researchers for product trials and feedback.
Capabilities
- WHO-GMP and ISO-compliant vaccine manufacturing facilities
- Dedicated SPF egg production farms
- In-house QC/QA and microbiological labs
- Custom vaccine formulation and autogenous vaccine development
- Cold chain infrastructure for safe and compliant transport
Indovax also provides technical training, vaccination protocols, and support for field teams and veterinarians.
Certifications and Compliance
- WHO-GMP Certified
- Complies with Indian Pharmacopoeia (IP) and OIE guidelines
- ISO 9001:2015 certified quality management
- Approved by Drug Controller General of India (DCGI)
- Products meet regulatory requirements of importing countries
All vaccines undergo batch-wise potency, sterility, and safety testing before release.
Customer Testimonials
- "Indovax’s POLYVAX vaccine is part of our standard protocol now. It's reduced handling time and ensured better immunity in flocks." – Technical Head, Leading Broiler Integrator, India
- "Reliable cold chain and timely delivery make Indovax our go-to partner for ND and IBD vaccination drives." – Government Poultry Officer, Africa
Major Achievements
- One of the first Indian companies to manufacture cell-associated Marek’s disease vaccine
- Built India’s only vertically integrated SPF egg and poultry vaccine production system
- Supplier to national and state-run poultry health programs
- Strategic collaborations with poultry research institutions and diagnostic labs
- Export expansion to over 25 countries with growing demand for inactivated multivalent vaccines
Indovax Private Limited continues to define excellence in poultry immunization by combining scientific integrity, production scale, and global outreach. Its focused commitment to avian health and biosecurity makes it a trusted name among poultry professionals, integrators, and veterinarians worldwide.
